These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26604012)

  • 1. Specific HDAC6 inhibition by ACY-738 reduces SLE pathogenesis in NZB/W mice.
    Regna NL; Vieson MD; Luo XM; Chafin CB; Puthiyaveetil AG; Hammond SE; Caudell DL; Jarpe MB; Reilly CM
    Clin Immunol; 2016 Jan; 162():58-73. PubMed ID: 26604012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Histone Deacetylase 6 Inhibition Normalizes B Cell Activation and Germinal Center Formation in a Model of Systemic Lupus Erythematosus.
    Ren J; Catalina MD; Eden K; Liao X; Read KA; Luo X; McMillan RP; Hulver MW; Jarpe M; Bachali P; Grammer AC; Lipsky PE; Reilly CM
    Front Immunol; 2019; 10():2512. PubMed ID: 31708928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo.
    Regna NL; Chafin CB; Hammond SE; Puthiyaveetil AG; Caudell DL; Reilly CM
    Clin Immunol; 2014 Mar; 151(1):29-42. PubMed ID: 24503172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC expression and activity is upregulated in diseased lupus-prone mice.
    Regna NL; Vieson MD; Gojmerac AM; Luo XM; Caudell DL; Reilly CM
    Int Immunopharmacol; 2015 Dec; 29(2):494-503. PubMed ID: 26471208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective HDAC6 inhibition decreases early stage of lupus nephritis by down-regulating both innate and adaptive immune responses.
    Ren J; Liao X; Vieson MD; Chen M; Scott R; Kazmierczak J; Luo XM; Reilly CM
    Clin Exp Immunol; 2018 Jan; 191(1):19-31. PubMed ID: 28876451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice.
    Reilly CM; Thomas M; Gogal R; Olgun S; Santo A; Sodhi R; Samy ET; Peng SL; Gilkeson GS; Mishra N
    J Autoimmun; 2008 Sep; 31(2):123-30. PubMed ID: 18650065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.
    Mina-Osorio P; LaStant J; Keirstead N; Whittard T; Ayala J; Stefanova S; Garrido R; Dimaano N; Hilton H; Giron M; Lau KY; Hang J; Postelnek J; Kim Y; Min S; Patel A; Woods J; Ramanujam M; DeMartino J; Narula S; Xu D
    Arthritis Rheum; 2013 Sep; 65(9):2380-91. PubMed ID: 23754328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics.
    Laino AS; Betts BC; Veerapathran A; Dolgalev I; Sarnaik A; Quayle SN; Jones SS; Weber JS; Woods DM
    J Immunother Cancer; 2019 Feb; 7(1):33. PubMed ID: 30728070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P; Langnickel D; Riemekasten G
    Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus.
    Decker DA; Grant C; Oh L; Becker PM; Young D; Jordan S
    Lupus; 2014 Jul; 23(8):802-12. PubMed ID: 24759631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution of severe combined immunodeficient mice with spleen cells from autoimmune NZBxNZW F1 mice.
    Ye YL; Chiang BL
    Clin Exp Rheumatol; 1998; 16(1):33-7. PubMed ID: 9543559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
    Starke C; Steinkasserer A; Voll RE; Zinser E
    Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin treatment attenuates proteinuria and prevents weight loss in NZB/W F1 mice.
    Paran D; Bernheim J; Golan I; Caspi D; Bernheim J; Benchetrit S
    Lupus; 2006; 15(8):526-31. PubMed ID: 16942006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17-β-estradiol affects BLyS serum levels and the nephritogenic autoantibody network accelerating glomerulonephritis in NZB/WF1 mice.
    Bassi N; Luisetto R; Ghirardello A; Gatto M; Valente M; Della Barbera M; Nalotto L; Punzi L; Doria A
    Lupus; 2015 Apr; 24(4-5):382-91. PubMed ID: 25801881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.
    Cheng Q; Mumtaz IM; Khodadadi L; Radbruch A; Hoyer BF; Hiepe F
    Ann Rheum Dis; 2013 Dec; 72(12):2011-7. PubMed ID: 24114925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model.
    Ko E; Lee Y; Park N; Cho C; Yim YN; Kim J; Kim YS; Kim D; Shin MK; Hong MC; Bae H
    Lupus; 2007; 16(5):335-41. PubMed ID: 17576735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raloxifene modulates estrogen-mediated B cell autoreactivity in NZB/W F1 mice.
    Zhang Y; Saha S; Rosenfeld G; Gonzalez J; Pepeljugoski KP; Peeva E
    J Rheumatol; 2010 Aug; 37(8):1646-57. PubMed ID: 20551107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased TGF-beta and decreased oncogene expression by omega-3 fatty acids in the spleen delays onset of autoimmune disease in B/W mice.
    Fernandes G; Bysani C; Venkatraman JT; Tomar V; Zhao W
    J Immunol; 1994 Jun; 152(12):5979-87. PubMed ID: 8207222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.